Kozma A - Search Results

1

Introduction of a Capillary Gel Electrophoresis-Based Workflow for Biotherapeutics Characterization: Size, Charge, and N-Glycosylation Variant Analysis of Bamlanivimab, an Anti-SARS-CoV-2 Product.

Szabo M, Sarkozy D, Szigeti M, Farsang R, Kardos Z, Kozma A, Csanky E, Chung DS, Szekanecz Z, Guttman A. Szabo M, et al. Among authors: kozma a. Front Bioeng Biotechnol. 2022 Mar 8;10:839374. doi: 10.3389/fbioe.2022.839374. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 35350184 Free PMC article.

2

Tocilizumab in Combination with Corticosteroids in COVID-19 Pneumonia: A Single-Centre Retrospective Controlled Study.

Kardos Z, Szabó M, Baráth Z, Miksi Á, Oláh C, Kozma Á, Gergely JA, Csánky E, Szekanecz Z. Kardos Z, et al. Among authors: kozma a. Biomedicines. 2023 Jan 26;11(2):349. doi: 10.3390/biomedicines11020349. Biomedicines. 2023. PMID: 36830885 Free PMC article.

3

Employing Young's modulus and Debye temperature to calculate the elastic, thermodynamic and thermophysical properties of titanium oxynitrides.

Kozma AA. Kozma AA. R Soc Open Sci. 2024 Oct 10;11(10):231797. doi: 10.1098/rsos.231797. eCollection 2024 Oct. R Soc Open Sci. 2024. PMID: 39391377 Free PMC article.

4

IGH::NSD2 Fusion Gene Transcript as Measurable Residual Disease Marker in Multiple Myeloma.

Bors A, Kozma A, Tomán Á, Őrfi Z, Kondor N, Tasnády S, Vályi-Nagy I, Reményi P, Mikala G, Andrikovics H. Bors A, et al. Among authors: kozma a. Cancers (Basel). 2024 Jan 9;16(2):283. doi: 10.3390/cancers16020283. Cancers (Basel). 2024. PMID: 38254774 Free PMC article.

5

Effective venetoclax-based treatment in relapsed/refractory multiple myeloma patients with translocation t(6;14).

Ceglédi A, Csukly Z, Fekete M, Kozma A, Szemlaky Z, Andrikovics H, Mikala G. Ceglédi A, et al. Among authors: kozma a. Pathol Oncol Res. 2023 Nov 10;29:1611375. doi: 10.3389/pore.2023.1611375. eCollection 2023. Pathol Oncol Res. 2023. PMID: 38025905 Free PMC article.

6

Our mutual friend, the prediction algorithm.

Kozma A. Kozma A. Nature. 2023 May 31. doi: 10.1038/d41586-023-01752-0. Online ahead of print. Nature. 2023. PMID: 37258734 No abstract available.

7

[Two myeloproliferative diseases in one patient - co-occurence of clones].

Fekete S, Reichardt J, Kozma A, Kapócs K, Meggyesi N. Fekete S, et al. Among authors: kozma a. Orv Hetil. 2022 Jul 10;163(28):1123-1129. doi: 10.1556/650.2022.32516. Print 2022 Jul 10. Orv Hetil. 2022. PMID: 35895464 Hungarian.

8

[Calreticulin: Pathophysiology of an unusual gain-of-function and its clinical consequences].

Kozma A, Meggyesi N, Hardi A, Ceglédi A, Tomán Á, Kapócs K, Mikala G. Kozma A, et al. Magy Onkol. 2022 Jun 20;66(2):147-152. Epub 2022 Apr 2. Magy Onkol. 2022. PMID: 35724392 Free article. Review. Hungarian.

9

Targeted Venetoclax Therapy in t(11;14) Multiple Myeloma: Real World Data From Seven Hungarian Centers.

Szita VR, Mikala G, Kozma A, Fábián J, Hardi A, Alizadeh H, Rajnics P, Rejtő L, Szendrei T, Váróczy L, Nagy Z, Illés Á, Vályi-Nagy I, Masszi T, Varga G. Szita VR, et al. Among authors: kozma a. Pathol Oncol Res. 2022 Feb 28;28:1610276. doi: 10.3389/pore.2022.1610276. eCollection 2022. Pathol Oncol Res. 2022. PMID: 35295611 Free PMC article.

10

Nucleophosmin1 and isocitrate dehydrogenase 1 and 2 as measurable residual disease markers in acute myeloid leukemia.

Kövy P, Őrfi Z, Bors A, Kozma A, Gopcsa L, Dolgos J, Lovas N, Harasztdombi J, Lakatos V, Király Á, Mikala G, Vályi-Nagy I, Reményi P, Andrikovics H. Kövy P, et al. Among authors: kozma a. PLoS One. 2021 Jun 21;16(6):e0253386. doi: 10.1371/journal.pone.0253386. eCollection 2021. PLoS One. 2021. PMID: 34153064 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

87 results

Search Page

Filters